Pharmaceutical Executive-01-01-2016

Pharmaceutical Executive

Feeling the Heat: Pharm Exec's 2016 Industry Forecast

January 29, 2016

Features

36

1

It’s easy to foresee controversy in 2016 as lagging global economic growth and a messy US political slugfest force the pharma industry’s feet to the fire. Can the industry reclaim a semblance of public approval by confronting its pricing demons and focusing on innovation and a fresh, patient-first message?

2016: A Biopharma Market in Flux

January 20, 2016

From the Editor

36

1

The changing tides in the global healthcare market are showing no signs of letting up. Here's my take on the opportunities, threats, and other big issues facing the industry in the new year.

Country Report: Puerto Rico

January 01, 2016

Special Sponsored Section

36

1

Confronted by a debt crisis and a stagnating economy, the government of Puerto Rico, the world’s fifth-largest pharma manufacturing producer, has turned to the healthcare industry-and life sciences in particular-for new sources of economic growth.

Pharmaceutical Executive, January 2016 Issue (PDF)

January 01, 2016

Issue PDF

36

1

Click the title above to open the Pharmaceutical Executive January 2016 issue in an interactive PDF format.